Correction: Longitudinal changes in circulating biomarkers from baseline to week 48 in treatment-Naïve people living with HIV initiating integrase inhibitor-based antiretroviral therapy
Jose-Ramon Blanco, CoRIS Cohort, Francisca Artigues, Julián Olalla(Hospital Costa del Sol), Laura Pérez‐Martínez(Hospital San Pedro), Miguel Torralba(Universidad de Alcalá), Helena Iglesias(Instituto Murciano de Investigación Biosanitaria), Mariano Matarranz del Amo, Joaquim Peraire(Instituto de Salud Carlos III), Enrique Bernal, María-Jesús Bustinduy-Odriozola, Alberto Delgado, Nisa Boukichou-Abdelkader, Sergio Padilla, Arkaitz Imaz, María Saumoy(Bellvitge University Hospital), Fernando Dronda, Antonia Alcaraz(Hospital Universitario Virgen de la Arrixaca)
Cited by 0
Related Papers
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study
|The Lancet HIV|2021|110
Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection
|EBioMedicine|2019|81
Low-Level Viremia Is Associated With Clinical Progression in HIV-Infected Patients Receiving Antiretroviral Treatment
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2018|80
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19
|Life Science Alliance|2022|52